Cerebellum-based Imaging Neural Markers for Antipsychotic Response — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Cerebellum-based Imaging Neural Markers for Antipsychotic Response — Stella

Home/Psychosis; Acute/

View on ClinicalTrials.gov

Recruiting

Back to Psychosis; Acute trials

Trial locations(1 site)

United States

Zucker Hillside Hospital, Glen Oaks, New York

Key details

Sponsor

Northwell Health

Collaborators

National Institute of Mental Health (NIMH)

Enrollment target

~120 participants

Started

November 2025

Primary completion

December 2029

Age range

16 Years – 40 Years

Last updated April 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.